Navigation Links
Warner Chilcott Announces Pricing of $500 Million of Senior Notes in Connection with Agreement to Acquire U.S. Rights to Enablex®
Date:9/24/2010

to Enablex®  

ARDEE, Ireland, Sept. 24 /PRNewswire-FirstCall/ -- Warner Chilcott plc (Nasdaq: WCRX) today announced that its subsidiaries, Warner Chilcott Company, LLC and Warner Chilcott Finance LLC (each a co-issuer, and together, the "Issuers"), sold $500 million aggregate principal amount of 7-3/4% Senior Notes due 2018 (the "Notes") in a private placement at a price of 102%. The Notes offering is expected to close on or about September 29, 2010. The Notes are additional notes constituting a part of the same series as the $750 million aggregate amount of 7-3/4% Senior Notes due 2018 issued on August 20, 2010.

The Issuers' obligations under the Notes will be guaranteed by Warner Chilcott plc and by its subsidiaries that guarantee obligations under Warner Chilcott's senior secured credit facilities, subject to certain exceptions.

As previously announced, Warner Chilcott intends to use the net proceeds from the offering to finance its $400 million upfront payment in connection with its pending acquisition of the U.S. rights to Enablex® from Novartis and for general corporate purposes.

The Notes have not been registered under the Securities Act of 1933, as amended. The Notes may not be offered or sold within the United States or to U.S. persons, except to "qualified institutional buyers" in reliance on the exemption from registration provided by Rule 144A and to certain persons in offshore transactions in reliance on Regulation S. This announcement does not constitute an offer to sell or the solicitation of an offer to buy Notes in any jurisdiction in which such an offer or sale would be unlawful.

About Warner ChilcottWarner Chilcott is a leading specialty pharmaceutical company currently focused on the gastroenterology, women's healthcare, dermatology and urology segments of the North American and Western European pharmaceuticals
'/>"/>

SOURCE Warner Chilcott plc
Copyright©2010 PR Newswire.
All rights reserved

0

GOOD

Page: 1 2 3 4 5 6 7 8

Related medicine technology :

1. Warner Chilcott Agrees to Terminate Existing Co-Promotion Agreement and Acquire U.S. Rights to Enablex® Overactive Bladder Treatment for $400 Million in Cash
2. Warner Chilcott Announces $500 Million Senior Notes Offering in Connection With Agreement to Acquire U.S. Rights to Enablex®
3. Warner Chilcott to Present at UBS Global Life Sciences Conference
4. Warner Chilcott Announces Receipt of FDA Response to Citizen Petition
5. Warner Chilcott Completes Amendment to Existing Senior Secured Credit Facilities and Closes Senior Notes Offering; Company Declares Special Cash Dividend of $8.50 Per Share and Updates Full-Year 2010 Financial Guidance
6. Warner Chilcott Announces Earnings Release Date and Conference Call for Second Quarter 2010 Financial Results
7. Warner Chilcott Announces 3-Month Extension of PDUFA Date on Next Generation Actonel Product
8. Warner Chilcott Announces Receipt of Paragraph IV Certification Notice
9. Warner Chilcott to Present at the Wells Fargo Securities Healthcare Conference
10. Warner Chilcott to Present at the Bank of America Merrill Lynch Healthcare Conference
11. Warner Chilcott Announces Earnings Release Date and Conference Call For First Quarter 2010 Financial Results
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:5/17/2013)... HILL, N.C. , May 17, 2013 /PRNewswire/ ... how organizations communicate internally. Faced with a constantly ... their strategies and tactics for communicating with internal ... effectiveness of all the strategies, tactics and tools ... In a new study, Best Practices, ...
(Date:5/17/2013)... Research explores data on treatments for ... to   be presented Shire plc ... specialty biopharmaceutical company, announces that it will present scientific ... Association (APA) 166th Annual Meeting in San ... represent Shire,s ongoing commitment to the clinical research of ...
(Date:5/17/2013)... 17, 2013 Fuse Science, Inc. (OTCQB: DROP), ( ... is developing new, patent-pending technologies poised to redefine how consumers ... will hold a business update teleconference and webcast for shareholders ... 2013 at 4:30 PM ET. Fuse Science, ... the call and will be joined by Rubin ...
Breaking Medicine Technology:Internal Communication Strategies and Tactics that Resonate with Key Stakeholders and Drive Organizational Effectiveness 2Shire to Present Scientific Data Across a Range of Psychiatric Disorders at American Psychiatric Association Annual Meeting 2Shire to Present Scientific Data Across a Range of Psychiatric Disorders at American Psychiatric Association Annual Meeting 3Shire to Present Scientific Data Across a Range of Psychiatric Disorders at American Psychiatric Association Annual Meeting 4Shire to Present Scientific Data Across a Range of Psychiatric Disorders at American Psychiatric Association Annual Meeting 5Shire to Present Scientific Data Across a Range of Psychiatric Disorders at American Psychiatric Association Annual Meeting 6Shire to Present Scientific Data Across a Range of Psychiatric Disorders at American Psychiatric Association Annual Meeting 7Shire to Present Scientific Data Across a Range of Psychiatric Disorders at American Psychiatric Association Annual Meeting 8Shire to Present Scientific Data Across a Range of Psychiatric Disorders at American Psychiatric Association Annual Meeting 9Shire to Present Scientific Data Across a Range of Psychiatric Disorders at American Psychiatric Association Annual Meeting 10Fuse Science, Inc. to Hold Business Update Webcast and Teleconference on May 22nd 2
... Scientific,Corporation (NYSE: BSX ) today announced ... press announcements at the Cardiovascular Research Foundation,s,(CRF) ... which runs from October 20 to 25 ... be announcing a wide range of safety ...
... the novel,selective relaxant binding agent (SRBA) being developed ... neuromuscular blockade as,compared to neostigmine in the Phase ... Spectrum, faster recovery from profound neuromuscular,blockade compared to ... were presented today at the 2007 annual meeting ...
Cached Medicine Technology:Boston Scientific to Release Broad Range of Clinical Trial Data Reinforcing Safety and Efficacy of Taxus(R) Coronary Stent Systems at TCT 2007 2Boston Scientific to Release Broad Range of Clinical Trial Data Reinforcing Safety and Efficacy of Taxus(R) Coronary Stent Systems at TCT 2007 3Boston Scientific to Release Broad Range of Clinical Trial Data Reinforcing Safety and Efficacy of Taxus(R) Coronary Stent Systems at TCT 2007 4Boston Scientific to Release Broad Range of Clinical Trial Data Reinforcing Safety and Efficacy of Taxus(R) Coronary Stent Systems at TCT 2007 5Boston Scientific to Release Broad Range of Clinical Trial Data Reinforcing Safety and Efficacy of Taxus(R) Coronary Stent Systems at TCT 2007 6Boston Scientific to Release Broad Range of Clinical Trial Data Reinforcing Safety and Efficacy of Taxus(R) Coronary Stent Systems at TCT 2007 7Sugammadex Trials Demonstrate Rapid Recovery from Profound Neuromuscular Blockade During General Anesthesia 2Sugammadex Trials Demonstrate Rapid Recovery from Profound Neuromuscular Blockade During General Anesthesia 3Sugammadex Trials Demonstrate Rapid Recovery from Profound Neuromuscular Blockade During General Anesthesia 4Sugammadex Trials Demonstrate Rapid Recovery from Profound Neuromuscular Blockade During General Anesthesia 5
(Date:5/19/2013)... Agora Health Limited developed by Rachael Linkie is ... how to increase memory power naturally and effectively. The ... people re-new their entire health from the inside out. It ... a fatigued mind. In addition, the program helps people keep ... The author claimed that this program can help people overcome ...
(Date:5/19/2013)... Rockford, IL (PRWEB) May 19, 2013 Beginning ... Rock River Valley Blood Center (RRVBC) will feature “Hot Dog ... and Belvidere. RRVBC will provide hot dogs and all ... feature ice-cold slushies each day throughout the summer. “Donors are ... to maintain a stable and adequate blood supply. This ...
(Date:5/19/2013)... HealthEconomics.Com , the global leader ... unveil a new and exciting service: HE-Xpo: a media-rich, ... array of real-time communication tools to expand their digital ... , HE-Xpo is powered by OnStream Media’s ... feel of being at a physical trade show, all ...
(Date:5/19/2013)... 2013 The Da Vinci robot lawyers ... in the nation’s first trial involving a Da Vinci ... State Superior Court, was filed by the widow of ... complications in a robot-assisted prostate removal, according to a ... robotic surgery lawsuit alleges those complication’s hastened his ...
(Date:5/18/2013)... 18, 2013 Daily Gossip issued a press ... review on their page. John Colston, Daily Gossip’s spokesperson, told ... Hadsall’s revolutionizing 14-Day Rapid Fat Loss Plan . ... carbs are healthy at a time when nutritionists and fat ... caloric products. , The diet is based on the ...
Breaking Medicine News(10 mins):Health News:How To Increase Memory Power | How “Agora Health Limited” Helps People Improve Their Memory Naturally And Effectively – Health Review 2Health News:Hot Dog Wednesdays and Ice Cold Slushies Return to Rock River Valley Blood Center for the Summer 2Health News:HealthEconomics.Com Announces HE-Xpo, a New Virtual Trade Show Devoted to Healthcare Value and Market Access 2Health News:HealthEconomics.Com Announces HE-Xpo, a New Virtual Trade Show Devoted to Healthcare Value and Market Access 3Health News:Da Vinci Surgical Robot Lawyers at Wright & Schulte LLC Note Recent Developments in Da Vinci Robot Lawsuit Trial 2Health News:Da Vinci Surgical Robot Lawyers at Wright & Schulte LLC Note Recent Developments in Da Vinci Robot Lawsuit Trial 3Health News:Da Vinci Surgical Robot Lawyers at Wright & Schulte LLC Note Recent Developments in Da Vinci Robot Lawsuit Trial 4
... States are worried that U.S. airlines could be on the ... deadly bird flu//., ,Health officials are already issuing guidelines ... are to be quarantined. The Federal officials are vested with ... of harboring the avian flu virus. The concerns are legitimate ...
... very famous saying which refers to an attitude when we ... and so feign that we are not concerned about it//. ... it's good; yet many people still avoid it, forgoing its ... researchers at the University of Illinois at Urbana-Champaign who studied ...
... children’s involved in bullying are equally stressed. Researchers from ... Pediatrics and Adolescent Medicine that psychologically both the group ... conducted in 3,350 students studying in three, four and ... consist of victims of bullying, bullies, both victims and ...
... new simple test that measures the eye movement of the ... Alcohol Spectrum Disorder (FASD) which would be useful in early ... ,"Having a set of tests that can be ... of the other behavioural disorders classified under the broader term ...
... The IBM Corp., based in Armonk, N.Y., announced ... three research centers, as part of an overall ... treatment//. ,IBM will collaborate with the Memorial ... the CHU Sainte-Justine Research Center under separate agreements. ...
... The Secretary of the National Commission on Macroeconomics and ... Union Government to make mandatory a comprehensive Universal Health ... the utilization of 9 % of the GDP on ... education, socio-economic growth and provision of basic infrastructural needs. ...
Cached Medicine News:Health News:Important parameters of life: Longevity and quality: both improved by exercise 2Health News:Important parameters of life: Longevity and quality: both improved by exercise 3Health News:Simple Eye Movement Test For Early Detection Of Fetal Alcohol Spectrum Disorder 2Health News:Crusade Against Cancer: Collaborations On The Anvil 2Health News:Need For Social Churning Emphasized In CMC Meet On ‘Leadership In Healthcare 2
... Self-Cath Closed System is a latex-free ... for safe, simple catheterization designed to ... infections. It includes a 100% ... new EasyOff tear tab makes it ...
... The Self-Cath family ... offers patients a variety ... self-catheterization. Each catheter ... medical grade PVC and ...
... family of 100% latex-free ... variety of options for ... catheter is made of ... and has smooth fire ...
An enzyme-linked immuno-sorbent assay for the detectionand quantitation of anti-tissue Transglutaminase in serum of patients with Celiac Disease and Dermatitis Herpetiformis....
Medicine Products: